Next Article in Journal
Sustained-Release and pH-Adjusted Alginate Microspheres-Encapsulated Doxorubicin Inhibit the Viabilities in Hepatocellular Carcinoma-Derived Cells
Next Article in Special Issue
Modification of the Release of Poorly Soluble Sulindac with the APTES-Modified SBA-15 Mesoporous Silica
Previous Article in Journal
Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells
Previous Article in Special Issue
An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(9), 1416; https://doi.org/10.3390/pharmaceutics13091416
Action Date Notes Link
article xml file uploaded 7 September 2021 12:40 CEST Original file -
article xml uploaded. 7 September 2021 12:40 CEST Update https://www.mdpi.com/1999-4923/13/9/1416/xml
article pdf uploaded. 7 September 2021 12:40 CEST Version of Record https://www.mdpi.com/1999-4923/13/9/1416/pdf
article supplementary file uploaded. 7 September 2021 12:40 CEST - https://www.mdpi.com/1999-4923/13/9/1416#supplementary
article html file updated 7 September 2021 12:42 CEST Original file -
article html file updated 9 September 2021 03:18 CEST Update -
article html file updated 30 July 2022 04:40 CEST Update https://www.mdpi.com/1999-4923/13/9/1416/html
Back to TopTop